ArticleJournal of global health2026
Global burden of maternal disorders, 1990-2021: insights from the Global Burden of Disease Study 2021 and challenges for achieving 2030 Sustainable Development Goals.
Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Magnesium sulfate for severe preeclampsia and eclampsia management at the primary healthcare level in sub-Saharan Africa: a systematic review.Frontiers in reproductive health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Sustainable Development Goals (SDGs) aim to reduce the global maternal mortality ratio (MMR) to below 70 deaths per 100 000 live births by 2030. However, progress has been uneven, with regional disparities and new challenges. We aimed to report global trends in maternal disorder burdens from 1990 to 2021. Methods: Using the Global Burden of Disease (GBD) 2021 database, we systematically analysed trends in incidence, mortality, and disability-adjusted life-years (DALYs) associated with maternal disorders from 1990 to 2021 and employed age-period-cohort (APC) models to assess changes in these indicators. For selected age-specific analyses, we additionally expressed incidence and DALY rates per 100 000 live births using age-specific fertility rates. We used the Bayesian APC model to forecast trends in maternal disorder incidence and mortality from 2022 to 2036. Results: From 1990 to 2021, there was a decrease in global incidence (38.5%), mortality (43.2%), and DALYs (61.4%) of maternal disorders. However, significant regional disparities persist. The burden was considerably lower in higher-sociodemographic-index regions than in sub-Saharan Africa. Maternal haemorrhage and hypertensive disorders continue to represent the primary causes of mortality, with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related deaths increasing, particularly among women aged 30-34 years and older. The APC model revealed that the age effect on maternal disorders initially decreased and then increased. The projected MMR of 136.5 (95% confidence interval = 100.2-172.7) per 100 000 live births by 2030 falls short of the SDG target of 70 maternal deaths per 100 000 live births, indicating a markedly insufficient annual reduction rate. Conclusions: Despite a decrease in the global burden of maternal disorders, regional disparities persist. Major challenges include haemorrhage, hypertensive disorders, and increasing HIV/AIDS-related deaths. Achieving SDG targets by 2030 requires universal access to quality maternal care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.